New hope for tough-to-treat myeloma: trial combines smart drugs to beat cancer
Disease control
Recruiting now
This trial is for people newly diagnosed with a high-risk form of multiple myeloma, a blood cancer. It tests several new drug combinations to see which works best at killing cancer cells and keeping the disease from coming back. About 300 participants will receive different treat…
Phase: PHASE2 • Sponsor: Multiple Myeloma Research Consortium • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC